Analysts' Actions: FCX BBBY CVS SD


Blackrock ( BLK) was initiated with an Overweight rating at JP Morgan. Equity and fixed-income ETF's can drive growth.

Davita ( DVA) was started with an Overweight rating at JP Morgan, which set a $125 price target. HCP purchase positions the company well for potential future growth.

Freeport-McMoran ( FCX) was upgraded from Hold to Buy at Deutsche Bank with a $40 price target. Stock appears oversold at current levels.

Flir Systems ( FLIR) was upgraded from Neutral to Buy at Sterne Agee with a $30 price target. Company appears to be back on the path toward solid growth.

Sandridge ( SD) was downgraded to Hold at Keybanc. Permian asset sale leaves questions about the company's remaining properties.

Silgan ( SLGN) was downgraded from Neutral to Sell at Goldman Sachs. Valuation call, based on a $42 price target.


Bed Bath & Beyond ( BBBY) numbers cut at Credit Suisse. Shares of BBBY now seen reaching $75, according to Credit Suisse. Estimates also reduced, given the company's new guidance. Outperform rating.

CVS Caremark ( CVS) numbers increased at Jefferies. CVS estimates were raised through 2014, Jefferies said. Company can expand margins and repurchase more shares. Buy rating and new $58 price target.
This article was written by a staff member of TheStreet.